4 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 4 of 4 clinical reviews.
A detailed breakdown of SURMOUNT-1's randomization, blinding, estimand framework, and statistical design, and why each methodological choice matters for interpreting tirzepatide's 20.9% weight-loss result.
Deep-dive into SURMOUNT-1 follow-up and extension findings for tirzepatide, covering weight regain after discontinuation, durability of cardiometabolic benefits, and emerging long-term safety signals.
A deep dive into the SURMOUNT-1 trial results for tirzepatide 5, 10, and 15 mg, covering primary and secondary endpoints, confidence intervals, weight-loss time course, and response distribution data beyond the abstract.
A plain-English deep dive into the SURMOUNT-1 trial, explaining how tirzepatide achieved up to 20.9% weight loss in adults with obesity and what that means for clinical practice.